Walgreens Boots Alliance Investors: Join Class Action for Recovery from Losses

Walgreens Boots Alliance Investors Urged to Join Class Action

SAN DIEGO, Feb. 23, 2025 – The law firm Robbins Geller Rudman & Dowd LLP has announced a significant opportunity for investors who acquired shares of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025. If you suffered considerable losses during this period, you may be eligible to lead a class action lawsuit against the company. This case, known as Klein v. Walgreens Boots Alliance, Inc. (No. 25-cv-01058, N.D. Ill.), accuses Walgreens and several of its current and former executives of violating the Securities Exchange Act of 1934.

Background of the Case

Walgreens operates as a major player in the healthcare, pharmacy, and retail sectors. The allegations stated in the class action lawsuit revolve around false statements made by Walgreens officials and their failure to disclose ongoing federal law violations related to prescription medication distribution. This alleged misconduct reportedly exposes investors to heightened risks of regulatory scrutiny and civil liabilities which further affect Walgreens' reputation and the sustainability of its revenue from prescriptions.

In a serious turn of events, on January 17, 2025, the U.S. Department of Justice announced a civil complaint against Walgreens. This complaint indicated that the company had “dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act and sought reimbursement from various federal health care programs, violating the False Claims Act.” Following this announcement, Walgreens stock saw a significant drop of over 12% within just two trading sessions.

How to Act

For investors wishing to serve as the lead plaintiff in this class action lawsuit, the deadline is set for Monday, March 31, 2025. Individuals who believe they are appropriate candidates should provide their information through the official Robbins Geller website or contact attorneys J.C. Sanchez or Jennifer N. Caringal directly at 800/449-4900 or via email at info@rgrdlaw.com. It’s crucial to act promptly, as being the lead plaintiff entails representing the broader group in this case.

The Private Securities Litigation Reform Act of 1995 allows investors who purchased shares during the defined class period to become lead plaintiffs. This role generally goes to the investor with the most substantial financial interest in the matter at hand, acting on behalf of their fellow class members. Lead plaintiffs have the option to choose their legal representatives while still maintaining their eligibility for recovery, regardless of whether they become the lead.

About Robbins Geller

Robbins Geller Rudman & Dowd LLP ranks among the top law firms for defending investor rights, boasting an exemplary record in securities fraud cases. The firm has secured over $6.6 billion in recoveries for investors in class action cases, establishing itself as a formidable advocate for those wronged in securities-related matters. With a dedicated team of approximately 200 attorneys across ten offices, Robbins Geller continues to operate at the forefront of legal expertise in this landscape, having achieved historic recoveries in cases like the Enron Corp. litigation.

Conclusion

For those impacted by the recent actions of Walgreens Boots Alliance, now is the time to engage in efforts to recover losses. Ensure your participation by reaching out to attorneys who can guide you through the process. This class action offers a path to seek justice and a potential recovery that aligns with your interests as an investor. More information is available on the Robbins Geller website, offering insights and resources to navigate this complex legal journey.